Novavax, Inc. (NVAX)
7.96
+0.26
(+3.38%)
USD |
NASDAQ |
Apr 06, 16:00
7.97
+0.01
(+0.13%)
After-Hours: 17:24
Novavax Market Cap : 1.245B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 298.97B |
| Pfizer Inc. | 157.31B |
| Moderna, Inc. | 19.01B |
| Intellia Therapeutics, Inc. | 1.555B |
| Recursion Pharmaceuticals, Inc. | 1.686B |
Market Cap Related Metrics
| PE Ratio | 3.344 |
| PS Ratio | 1.209 |
| Price | 7.96 |
| Earnings Yield | 29.91% |
| Operating PE Ratio | 2.411 |
| Normalized PE Ratio | 2.685 |